Laura Minquini, founder of AthenaDAO and now the nonprofit AthenaBio, argues that female lifespan gains are undermined by decades spent in a postmenopausal state of diminished physiological reserve. Her work directs capital toward ovarian aging research, positioning the ovary as an early-failing organ whose decline precedes and accelerates systemic aging in women.
Key Points
- Women outlive men but accrue more years in compromised health
- Ovarian decline precedes broader systemic aging by decades
- AthenaBio channels philanthropic capital into underfunded reproductive aging science
Longevity Analysis
Ovarian function declines roughly a decade before most other organs, and its withdrawal reshapes bone density, vascular tone, cognition, metabolic regulation, and sleep architecture simultaneously. Treating menopause as a discrete gynecological event rather than a whole-body hormonal transition obscures the earliest actionable window for intervention. Research capital directed at the timing of that transition addresses a gap that affects half the population across thirty or more years of life.
Original published by LifeSpan.io, by Arkadi Mazin.